These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Severe hyperlipidemia due to multiple factors in a child with nephrotic syndrome. Ongkingco JR, Mann WA, Ruley EJ, Gregg RE. Child Nephrol Urol; 1991; 11(2):107-10. PubMed ID: 1756519 [Abstract] [Full Text] [Related]
4. Rationale and management of hyperlipidemia of the nephrotic syndrome. Grundy SM, Vega GL. Am J Med; 1989 Nov; 87(5N):3N-11N. PubMed ID: 2486542 [Abstract] [Full Text] [Related]
7. Hepatic tissue sterol regulatory element binding protein 2 and low-density lipoprotein receptor in nephrotic syndrome. Kim CH, Kim HJ, Mitsuhashi M, Vaziri ND. Metabolism; 2007 Oct; 56(10):1377-82. PubMed ID: 17884448 [Abstract] [Full Text] [Related]
11. Lipid abnormalities in chronic renal failure, nephrotic syndrome and dialysis. Kes P. Acta Med Croatica; 2001 Dec 15; 55(4-5):177-86. PubMed ID: 12398021 [Abstract] [Full Text] [Related]
12. Proteinuria, hyperlipidemia, and the kidney. Hutchison FN. Miner Electrolyte Metab; 1993 Dec 15; 19(3):127-36. PubMed ID: 8232099 [Abstract] [Full Text] [Related]
16. [Dyslipidemias in renal diseases: pathogenesis and treatment]. Cuevas A, Maíz A, Arteaga A. Rev Med Chil; 1998 Mar 30; 126(3):315-21. PubMed ID: 9674303 [Abstract] [Full Text] [Related]
17. Nephrotic syndrome in adults: diagnosis and management. Kodner C. Am Fam Physician; 2009 Nov 15; 80(10):1129-34. PubMed ID: 19904897 [Abstract] [Full Text] [Related]
18. The potential role of HMG-CoA reductase inhibitors in pediatric nephrotic syndrome. Prescott WA, Streetman DA, Streetman DS. Ann Pharmacother; 2004 Dec 15; 38(12):2105-14. PubMed ID: 15507504 [Abstract] [Full Text] [Related]
19. [Lipoprotein disorders in chronic kidney failure, nephrotic syndrome and dialysis]. Kes P, Reiner Z, Brunetta B. Lijec Vjesn; 2002 Dec 15; 124(11-12):372-7. PubMed ID: 12679979 [Abstract] [Full Text] [Related]